Immunological control of fertility: measurement of affinity of antibodies to human chorionic gonadotrophin.
Four baboons were primed with diazotized beta human chorionic gonadotrophin and boosted with diazotized C-terminal beta human chorionic gonadotrophin peptide, and the changes in antibody amount and affinity determined using a double isotope modified Farr assay, using labelled human chorionic gonadotrophin as the antigen. The degree of cross-reaction with human luteinizing hormone was also determined. Although appreciable reactivity with luteinizing hormone was observed soon after immunization, this declined rapidly during the response. At the time intervals studied, there was a progressive increase in affinity of antibodies to human chorionic gonadotrophin until day 248 after priming. At day 313, in two of the animals, there was a decrease in affinity from 1.04 X 10(11) to 6.80 X 10(10) and 1.05 X 10(11) to 4.93 X 10(10) l/mol, whereas in the other two baboons there was a further increase in antibody affinity. At corresponding time intervals, there was a steady decrease in values of total antibody binding sites. To determine the overall effect of the maturation of affinity with a decrease in antibody amount on biological efficacy, the theoretical amount of chorionic gonadotrophin that would be neutralized was calculated. We computed that in all instances, over 99% of a peak concentration of chorionic gonadotrophin that could be in circulation in a pregnant baboon would be neutralized. This was in excellent agreement with results of mating experiments in these baboons. In over forty cycles studied, none of the matings resulted in a sustained pregnancy.
D000818:Animals; D000915:Antibody Affinity; D000917:Antibody Formation; D001666:Binding Sites, Antibody; D006063:Chorionic Gonadotropin / Q000276:immunology*; D003267:Contraception; D003269:Contraception, Immunologic; D003429:Cross Reactions; D003979:Diazonium Compounds / Q000276:immunology; D005260:Female; D000882:Haplorhini; D006241:Haptens / Q000276:immunology; D007986:Luteinizing Hormone / Q000276:immunology; D010215:Papio; D010455:Peptides / Q000276:immunology; D013997:Time Factors
D006063:Chorionic Gonadotropin; D003979:Diazonium Compounds; D006241:Haptens; D010455:Peptides; D007986:Luteinizing Hormone